SCHEMBL7001440

SCHEMBL7001440

CC1Oc2c(Cl)cc([N+](=O)[O-])cc2NC1=S

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 2/20 0.35
GPR35 Q9HC97 1/20 0.35
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
ALOX15 P16050 1/20 0.31
BRD4 O60885 1/20 0.31
TSHR P16473 1/20 0.31
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
PGR P06401 1/20 0.30
KMT2A Q03164 2/20 0.30
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
AKR1B1 P15121 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8111545 0.89 GPR35 (0.36) ALDH1A1GPR35CYP3A4AKR1B1
SCHEMBL6999227 0.85 ALDH1A1 (0.41) ALDH1A1HSD17B10GPR35LMNAHTT
SCHEMBL7981459 0.78 AKR1B1 (0.33) AKR1B1
SCHEMBL6996429 0.75 ALDH1A1 (0.40) ALDH1A1HSD17B10CYP1A2CYP3A4ALOX15
SCHEMBL6999139 0.73 AKR1B1 (0.39) ALDH1A1GPR35LMNACYP1A2CYP3A4
SCHEMBL7003210 0.72 KMT2A (0.48) ALDH1A1HSD17B10CYP1A2CYP3A4ALOX15
SCHEMBL6999113 0.71 ALDH1A1 (0.46) ALDH1A1HSD17B10GPR35HTTCYP3A4
SCHEMBL7710726 0.70 ALDH1A1 (0.45) ALDH1A1HSD17B10GPR35LMNAHTT
SCHEMBL20265314 0.69 ALDH1A1 (0.44) ALDH1A1HSD17B10GPR35ADRA2AADRA2B
SCHEMBL16844142 0.66 ALDH1A1 (0.38) ALDH1A1HSD17B10GPR35LMNAADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed